The Clinical Investigator as an Endangered Species

E. J. Volpintesta, Charles Homer, Kenneth P. Wolski, James C. Allen, Scott Kaufmann, Steven R. Cohen, James B. Wyngaarden

Research output: Contribution to journalLetter

1 Scopus citations

Abstract

To the Editor: Dr. Wyngaarden's suggestion in the December 6 issue that the clinical investigator be placed on the endangered-species list warrants an afterthought. Certainly, the reports that he cites disclose that the number of M.D.'s entering medical research as a primary career is declining steadily. In addition, the number of scholarships and research awards proffered to encourage M.D.'s to pursue medical research is waning. Dr. Wyngaarden's study also indicates that the number of Ph.D.'s involved in medical research is concomitantly increasing. He implies that the end result of all this will be deleterious to medical progress and medical pedagogy,. . . No extract is available for articles shorter than 400 words.

Original languageEnglish (US)
Pages (from-to)926-928
Number of pages3
JournalNew England Journal of Medicine
Volume302
Issue number16
DOIs
StatePublished - Apr 17 1980

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The Clinical Investigator as an Endangered Species'. Together they form a unique fingerprint.

  • Cite this

    Volpintesta, E. J., Homer, C., Wolski, K. P., Allen, J. C., Kaufmann, S., Cohen, S. R., & Wyngaarden, J. B. (1980). The Clinical Investigator as an Endangered Species. New England Journal of Medicine, 302(16), 926-928. https://doi.org/10.1056/NEJM198004173021627